Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Metabolomic profiling of triple negative breast cancer cells suggests that valproic acid can enhance the anticancer effect of cisplatin.
Front Cell Dev Biol. 2022 Dec 5;10:1014798. doi: 10.3389/fcell.2022.1014798. eCollection 2022.
Front Cell Dev Biol. 2022.
PMID: 36544904
Free PMC article.
Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance.
Alkhatib H, Rubinstein AM, Vasudevan S, Flashner-Abramson E, Stefansky S, Chowdhury SR, Oguche S, Peretz-Yablonsky T, Granit A, Granot Z, Ben-Porath I, Sheva K, Feldman J, Cohen NE, Meirovitz A, Kravchenko-Balasha N.
Alkhatib H, et al. Among authors: peretz yablonsky t.
Genome Med. 2022 Oct 20;14(1):120. doi: 10.1186/s13073-022-01121-y.
Genome Med. 2022.
PMID: 36266692
Free PMC article.
Item in Clipboard
Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer.
Alkhatib H, Conage-Pough J, Roy Chowdhury S, Shian D, Zaid D, Rubinstein AM, Sonnenblick A, Peretz-Yablonsky T, Granit A, Carmon E, Kohale IN, Boughey JC, Goetz MP, Wang L, White FM, Kravchenko-Balasha N.
Alkhatib H, et al. Among authors: peretz yablonsky t.
Mol Cancer. 2024 Jan 16;23(1):17. doi: 10.1186/s12943-023-01921-9.
Mol Cancer. 2024.
PMID: 38229082
Free PMC article.
Item in Clipboard
Cite
Cite